Successful Treatment of Persistent SARS-CoV-2 Infection in an Immunocompromised Patient

Posted 3 years ago

Recent Publications

Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment October 24, 2025 Marie Wijk
Tuberculosis Disease Prevalence Among People Who Smoke Illicit Drugs: A Respondent- Driven Sampling Study in the Western Cape, South Africa October 8, 2025 Samantha Malatesta
Social Vulnerability Modifies the Effects of Geographic Proximity on Engagement in Latent Tuberculosis Infection Care in a United States Safety Net Healthcare Network July 3, 2025 Jeffrey I Campbell
Pitfalls of bacterial pan-genome analysis approaches: a case study of Mycobacterium tuberculosis and two less clonal bacterial species May 9, 2025 Maximillian G Marin
Barriers to recruitment of an observational SARS-CoV-2 emergency department cohort at Boston Medical Center April 20, 2025 Sarah J Thomson
Inferring bivariate associations with continuous data from studies using respondent-driven sampling March 17, 2025 Samantha Malatesta
A Pragmatic Approach to Handling Censored Data Below the Lower Limit of Quantification in Pharmacokinetic Modeling March 11, 2025 Marie Wijk
Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis February 20, 2025 Christine A Tzelios
Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk October 31, 2024 Pamela M Murnane
Understanding the impact of pandemics on long-term medication adherence: directly observed therapy in a tuberculosis treatment cohort pre- and post-COVID-19 lockdowns October 13, 2024 Victoria Overbeck